report in-lin membership mix
skew medicar
updat forecast estim jul
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jul
estim jul
price data aug
rate updat aug
currenc amount express
valuat growth profit
methodolog valu compani
even sure difficult oper environ
core manag care busi believ unitedhealth
possess materi competit advantag allow
produc outsiz econom profit extend period
busi outlook health insur fill
uncertainti unit built
power
all-encompass healthcar player believ domin
forc next sever decad
unit construct optum divis one
power healthcare-servic player posit firm
advantag long term acquisit
narrow-moat catamaran unit built pbm
oper major forc pharmaceut market
perspect optumrx strong valu driver unit
next sever year firm also move becom
major player healthcar market optumhealth
optuminsight line though busi unit major
patient popul provid
infrastructur manag market believ busi
line offer signific growth opportun unit
allow off-set signific portion headwind face
within oper
industri encompass significantli greater
degre competit cost cap gross profit
mandat medic loss ratio mlr player
larg suffici divers membership base abl
earn econom profit ad pressur oper
environ extrem polit legisl uncertainti
come washington volatil eman congress
administr inject major uncertainti
headwind health insur market
nevertheless believ unit exchang strategi lessen
regulatori risk greatli individu membership decreas
level firm continu exit troubl
public exchang market perspect decis exit
vast major state exchang prudent
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
consist among top perform health
insur million cover live billion
annual process prescript claim one largest
mco pbm unit state firm provid health insur
servic member fulli insur fee-bas plan everi
major insur market -- individu employ govern sponsor
firm also major player within healthcar space provid
manag back-offic servic provid smaller/mids
health insur optum segment segment like drive
signific portion growth unit long term
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
report in-lin membership mix
skew medicar jul
major surpris
second quarter reiter fair valu
estim narrow moat rate managed-car firm
remain flat year-ago level slightli lower
medic loss ratio off-set slightli higher oper
cost ratio lower medic loss ratio posit
expect trend revers next sever
quarter util rate start tick due
continu mix shift toward higher-cost medicar
medicaid quarter employer- commercial-bas
membership decreas year year medicare/
medicaid membership increas time
perspect believ secular growth trend
within health insur market larg driven
higher-cost medicar medicaid cohort
member make risk pool tend skew older
sicker thu usual carri materi high level
medic cost shift membership growth
believ essenti unit control oper cost
previou quarter manag keen
highlight perform
optum oper
manag clearli see vari healthcar servic
busi key long-term valu gener posit
believ unit posit busi key
player within healthcar market primari
driver earn growth next hand year
quarter optum abl drive revenu growth
expand oper margin impress
perform believ servic highli
benefici sharehold
valuat growth profit
increas fair valu estim unit
factor tax rate
line recent pass tax reform legisl
addit perform high level
despit volatil oper environ impress
firm abl produc given
precari legisl issu eman washington
believ combin posit health insur
market strategi strong execut firm optum
segment buoy healthcare-servic player given
unit recent result strong strategi believ
abl perform moder better previou
assumpt reflect specif increas
oper margin assumpt averag
previou assumpt drive
posit outlook unit prudent decis exit vast
major state exchang stop activ seek new
membership other even though dynam creat
revenu growth headwind manag care segment
help avoid potenti loss lessen oper risk
preserv sharehold return addit firm
underwritten extrem well believ trend
continu explicit forecast
process
posit unit also grown number prescript
pbm oper
approxim billion annual result firm
abl obtain top-tier supplier price discount
scale advantag believ firm continu
increas prescript claim time also expand
profit claim gain upper hand
supplier
five-year explicit forecast project oper
revenu revenu exclud invest incom grow
compound annual rate also model oper
margin averag compar
oper revenu compound-annual-growth-rate averag oper
margin past five year factor
moder per-memb premium growth along
increas per-memb medic cost
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
place greater pressur upon industri player
scenario assum neg premium growth
greater competit higher due more-string
govern regul stagnant membership growth
littl growth higher-cost market less
posit scale factor sg expens
scenario fair valu estim decreas per
moat continu one strongest-perform
healthcare-servic firm next sever decad
firm histor top-tier perform within
sector expect trend continu well
next sever year addit seri
acquisit organ growth unit becom one
three major pbm process approxim
billion prescript claim annual variabl
endow unit abil churn long-term
leverag larg divers membership
base unit establish gold-standard
solid line-up product particip major
diversif shield unit advers develop
top-tier pbm recent acquisit narrow-moat
catamaran firm abil negoti highli
favor drug price player along
pharmaceut suppli chain factor give
advantag grow client base provid low-cost
product time preserv gross
margin scale also sourc competit advantag
addit claim process profit
previou central technolog system cost
abl spread across entir level claim
clearli give advantag larger pbm believ
anticip neg trend posit scale trend
sell gener administr cost revenu
mix-shift toward higher profit optum busi
scenario analysi take consider chang
sg scale result mandat
bull-cas scenario factor slightli posit
premium growth consolid medic loss ratio
slightli lower base-cas assumpt
increas membership growth firm commerci risk
busi greater sg cost scale scenario
believ exchang market less catalyst
greater industri transpar competit
addit assum secular trend large-group
custom migrat fee-bas plan slow moder
scenario fair valu estim increas
bear case assum feder govern
becom even punit toward industri
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
privat public medic program oper
seen major growth driver come
year howev poor state feder govern budget
along aca-mand payment cut
combin effect pressur profit
industri face materi greater degre
transpar shift certain advantag away
insur consum competit increas
mco seek build exchang oper augment
commerci membership greater regul gross
profit cap certain product add industri
headwind give mco major growth
opportun growth come lower level profit
capit return
competit advantag form solid bedrock narrow
believ five major mco coverag
neg moat trend result effort
repeal certain provis within act oper
environ mco significantli pressur
long term industri encompass
greater degre transpar increas competit
give mco signific growth
opportun growth come
profit addit new govern regul
effect commodit product
format commun
underwrit narrow band premium fluctuat
minimum medic loss ratio exchang plan
effect cap gross profit major
addit believ greater integr
provid payer better control cost
done combin capit payment
pay fix payment provider/network
provider/network share cost save
respons overag amalgam certain
provid network build effici account
care organ merger physic provid
asset mco believ factor like
depress aggreg roic industri major
player current cover strateg acquir
physician offic geograph risk-pool
specif probabl trend expand materi
opinion could hurt capit return
major materi oper depend
govern fund -- medicar medicaid dual-elig
program medicaid expans growth
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ounitedhealth largest divers
membership base within health insur market
give signific competit advantag among
major health insur
oth reform healthcar market
volatil relat potenti chang
mandat built unpreced uncertainti
oper environ
oth firm diversif high margin healthcar
servic nich give opportun increas
bottom line high growth market nich
unit solidifi major pbm oper
reap signific long-term econom profit
billion annual prescript claim possess
oincreas competit pressur price profit
mco
rate steep downward trend
pressur one largest sourc revenu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
unit rel strong financi health firm
highli strong pbm hcit servic asset produc
excel free cash flow divers healthcare-services-rel
oper provid solid foundat long-term financi
stabil firm debt/ebitda ratio stand
manag time forese major
deviat level
uncertainti permeat industri thick
 struggl best control healthcar cost
preserv access best treatment regimen increas
regul competit pressur industri player
time come decreas payment rate
government-sponsor medic program add
heighten uncertainti mco howev even
larg amount risk face believ
posit work headwind fact
larg growth opportun given expand medic
coverag materi portion resid
lessen uncertainti qualiti mco
abl leverag narrow
econom moat profit take advantag chang
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
va collegeamerica growth fund america
fidel manag research compani
share
fund
share
fund
believ top-tier manag team
deliv excel result firm longtim
ceo stephen hemsley recent retir turn top
posit david wichmann serv
unit presid sinc novemb wichmann
signific influenc strategi firm
past year held sever execut role
time period experi prudent
transit plan process year
believ unit solid stewardship continu churn
excel sharehold return
firm consist outperform peer
past sever year built strong reput
among provid regul custom unit one
largest health insur approxim
million medic member one largest pbm
approxim billion annual prescript claim
firm strategi build strong core membership
base given solid platform oper apart
core oper firm manag team
also built unit health care servic powerhous
optum divis drive good amount valu
firm optumrx pbm one largest
payer within pharmaceut industri
acquisit narrow-moat catamaran manag
move optumrx top-tier pharmaceut player
given sharehold anoth sourc signific
long-term valu creation result
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
despit amazon acquisit pillpack market
june amazon announc purchas mail-ord
pharmaci start-up pillpack move give amazon
foothold within pharmaceut suppli chain
logic step on-line conglomer make
believ retail pharmaci go easiest
segment pharmaceut suppli chain amazon
enter howev also believ still tough
firm creat major disrupt within healthcar
space given insur dynam drive market
perspect new competitor need deal
larg power custom despit
market particip believ true end custom
pharmaceut space consum drug
rather insurer/employer/govern pay
health benefit consum accordingli expertis
need profit navig space preclud easi
opportun new entrant believ current
downward stock price move fear new disrupt
competit drug space creat opportun
investor acquir solid moati firm drug wholesal
pbm industri discount
perspect three key variabl
overlook market particip
stakehold analyz potenti new meaning
competit within pharmaceut market
true custom along chain busi
provid health benefit consum provid
health benefit make almost decis regard drug
pharmaci access busi also sourc suppli
drug partnership togeth b-to-b market
develop use drug health insur
base treat medic ailment consum demand
cash pay market estim less
prescript paid consum directli cash-
pay basi without insur dynam would take
mani consumer-bas compani built
core-compet get involv
pharmaceut space
price pharmaceut
drug price high-profil issu engulf
pharmaceut space percept new
entrant particular amazon instantli enter space
cut price drug product howev actual
price drug alreadi low given massiv amount
buy power pbm drug wholesal retail
pharmaci accumul new entrant would hold
minuscul amount purchas power compar
massiv joint sourc ventur
develop last hand year thu level
gener drug discount brand drug rebat new
entrant could command would pale comparison
major pharma supply-chain player make difficult
price competit
access global suppli drug requir
viabl player within pbm pharma wholes
retail pharmaci space access everi legitim drug
requir due variabl demand health
insur product viabl pharma player need abl
access plethora drug
manufactur across world level access
achiev major drug market servic player
new entrant reach level
option clear major drug benefit provid
seller purchas pharmaceut
detail analysi competit dynam
pharmaceut space amazon podeti disrupt
pleas see report sell drug easier said done
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
moati pharma channel
unitedhealth increas access low-cost diagnost
lab labcorp quest may
long-stand exclus contract labcorp
primari in-network diagnost lab final extinguish
announc would maintain
relationship labcorp also fulli bring
in-network start although
announc shift fair valu estim
three narrow-moat compani news
provid lift labcorp quest whose share
trade tightli around intrins valu
though possibl labcorp lose contract
hover lab firm last year
thought much like payer would
add quest mix rather replac labcorp quest
unlik last time exclus lab contract
exchang hand quest labcorp payer
far focus reduc use high-cost provid
otherwis known hospital-bas lab secur
lowest price possibl two lab competitor
alreadi lowest-cost produc industri
thank afford act particip
therapeut maker -- evolv align
interest around better health outcom effici
use resourc payer gotten seriou appli
carrot stick encourag provid move away
higher-cost hospital-bas lab increas access
lowest-cost option labcorp quest
unitedhealth strateg allianc
independ lab also mean gain access
diagnost test data real time allow payer move
closer point provid made actual
treatment decis anticip three firm
come new approach value-bas
reimburs lab
solid perform optum drive unit result
report first-quart result fell line
expect reiter fair
valu estim narrow moat rate managed-
care organ remain bearish stock
valuat given concern core health insur
oper howev next sever year expect
firm optum divis drive solid result first-
quarter result reflect trend firm report excel
revenu growth profit expans optum divis
perspect healthcar firm provid cost
save effici servic thrive come
decad backdrop believ unit
built formid healthcar servic player optum
busi highli benefici sharehold
given overal outlook healthcar market
despit good result healthcare-servic
divis unit core health insur oper mix
result revenu growth strong flat profit
margin firm abl leverag increas premium
due resumpt afford act insur fee
insur rais premium off-set fee drive
lower medic loss ratio howev tailwind off-set
increas administr expens due
drill membership firm drove strong sequenti
growth medicar cohort balanc book
decreas slightli medicar major driver
membership growth come year gross
profit yield plan like materi less
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
core employ plan histor
compos major unit insur oper
thu believ essenti firm keep
administr cost check watch close
variabl develop next sever quarter
factor affect insur fee expect
oper cost ratio least hold steadi
unit individu membership decreas
year-ago level firm continu exit
troubl public exchang market perspect
mco decis exit vast major state exchang
stop activ seek new membership other
prudent even though dynam creat slight revenu
growth headwind believ help avoid
potenti loss lessen oper risk preserv
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
